Description
Trazumab 440mg Injection is a targeted therapy medication used in the treatment of certain types of cancer, primarily HER2-positive breast cancer and HER2-positive metastatic gastric cancer. The active ingredient, Trastuzumab, is a monoclonal antibody that specifically targets the HER2 protein, which is overexpressed in some cancer cells. By binding to HER2, Trazumab inhibits the growth and proliferation of these cancer cells. It works by blocking signaling pathways that promote cell growth and by marking cancer cells for destruction by the body’s immune system. Trazumab is administered intravenously by a healthcare professional. The typical dosage and treatment schedule will be determined by your oncologist based on your specific condition and response to treatment. Common side effects may include infusion-related reactions (fever, chills, shortness of breath), fatigue, nausea, vomiting, and diarrhea. Less common but serious side effects can include heart problems and lung toxicity. It is crucial to discuss any pre-existing medical conditions, especially heart conditions, with your doctor before starting treatment. Trazumab 440mg Injection should be stored as directed by the manufacturer, typically refrigerated and protected from light.
